Pharmacokinetics and Safety of iGlarLixi in Healthy Chinese Participants: Results of a Phase 1 Randomized Study.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 8, p. 1387, doi. 10.1007/s13300-023-01434-0
- By:
- Publication type:
- Article
Works matching IS 18696953 AND DT 2023 AND VI 14 AND IP 8
Results: 13
1
2
Time in Range Estimation in Patients with Type 2 Diabetes is Improved by Incorporating Fasting and Postprandial Glucose Levels.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 8, p. 1373, doi. 10.1007/s13300-023-01432-2
- By:
- Publication type:
- Article
3
Expanding the Role of Continuous Glucose Monitoring in Modern Diabetes Care Beyond Type 1 Disease.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 8, p. 1241, doi. 10.1007/s13300-023-01431-3
- By:
- Publication type:
- Article
4
Atherosclerotic Cardiovascular Disease in Type 2 Diabetes: A Retrospective, Observational Study of Economic and Clinical Burden in Sweden.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 8, p. 1357, doi. 10.1007/s13300-023-01430-4
- By:
- Publication type:
- Article
5
Healthcare Professionals' Knowledge of and Attitudes Towards the Use of Time in Range in Diabetes Management: Online Survey Across Seven Countries.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 8, p. 1399, doi. 10.1007/s13300-023-01429-x
- By:
- Publication type:
- Article
6
Circulating Cytokine Levels and Cardiovascular Disease Risk Profile in Young Adult Offspring of Women with Type 1 Diabetes.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 8, p. 1427, doi. 10.1007/s13300-023-01428-y
- By:
- Publication type:
- Article
7
Real-World User and Clinician Perspective and Experience with MiniMed™ 780G Advanced Hybrid Closed Loop System.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 8, p. 1319, doi. 10.1007/s13300-023-01427-z
- By:
- Publication type:
- Article
8
Emerging Adult and Caregiver Psychosocial Experiences with Severe Hypoglycemic Events and the Perceived Impact of Nasal Glucagon: A Cross-Sectional Study.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 8, p. 1285, doi. 10.1007/s13300-023-01425-1
- By:
- Publication type:
- Article
9
Childhood Obesity and Essential Micronutrients: Insights from India's Comprehensive National Nutrition Survey (2016–18).
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 8, p. 1267, doi. 10.1007/s13300-023-01424-2
- By:
- Publication type:
- Article
10
Real-World Effects of Second-Generation Versus Earlier Intermediate/Basal Insulin Analogues on Rates of Hypoglycemia in Adults with Type 1 and 2 Diabetes (iNPHORM, US).
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 8, p. 1299, doi. 10.1007/s13300-023-01423-3
- By:
- Publication type:
- Article
11
Clinical Benefits of Treating Patients with Type 2 Diabetes Mellitus with iGlarLixi: A Patient-Level Simulation Study.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 8, p. 1331, doi. 10.1007/s13300-023-01419-z
- By:
- Publication type:
- Article
12
Greater Combined Reductions of HbA<sub>1c</sub> ≥ 1.0% and Body Weight Loss ≥ 5.0% or ≥ 10.0% with Orally Administered Semaglutide Versus Comparators.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 8, p. 1415, doi. 10.1007/s13300-023-01413-5
- By:
- Publication type:
- Article
13
A Qualitative Research Study of Experiences and Perceptions of People Living with Insulin Resistance Syndrome or Lipoatrophic Diabetes in Japan.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 8, p. 1345, doi. 10.1007/s13300-023-01412-6
- By:
- Publication type:
- Article